Figure 4. Meta-analysis of the use of angiotensin converting enzyme (ACE) inhibitors on the risk of pneumonia related mortality. Pneumonia related mortality was reduced by 27% (OR: 0.73; 95% CI, 0.59 to 0.90; p=0.004) in patients using angiotensin converting enzyme (ACE) inhibitors.